SEC Form 4 · accession 0001179110-18-012095
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam C Vandervoort
Officer — Chief Legal Officer, Secretary
Period of report
Oct 8, 2018
Accepted (ET)
Oct 9, 2018 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 8, 2018 | M | 2,734 | $8.71 | A | 2,934 | D | |
| Common Stock | Oct 8, 2018 | M | 456 | $9.60 | A | 3,390 | D | |
| Common Stock | Oct 8, 2018 | M | 914 | $12.21 | A | 4,304 | D | |
| Common Stock | Oct 8, 2018 | M | 1,447 | $22.30 | A | 5,751 | D | |
| Common StockF2 | Oct 8, 2018 | S | 5,551 | $73.83 | D | 200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $8.71 | Oct 8, 2018 | M | 2,734 | D | — | Feb 25, 2025 | Common Stock | 2,734 | 13,670 | D |
| Employee Stock Option (right to buy)F4 | $9.60 | Oct 8, 2018 | M | 456 | D | — | May 29, 2025 | Common Stock | 456 | 3,645 | D |
| Employee Stock Option (right to buy)F5 | $12.21 | Oct 8, 2018 | M | 914 | D | — | Mar 7, 2026 | Common Stock | 914 | 15,530 | D |
| Employee Stock Option (right to buy)F6 | $22.30 | Oct 8, 2018 | M | 1,447 | D | — | Mar 3, 2027 | Common Stock | 1,447 | 41,955 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
- F2Represents the weighted average price of transactions ranging from $73.30 to $74.62. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F4The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F5The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F6The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.